𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐍𝐞𝐰𝐛𝐨𝐫𝐧 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞, 𝐒𝐡𝐚𝐫𝐞 & 𝐆𝐫𝐨𝐰𝐭𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟐𝟓-𝟐𝟎𝟑𝟓)
𝐃𝐞𝐭𝐚𝐢𝐥𝐞𝐝 𝐑𝐃- https://lnkd.in/dgM4Yq8y
The North America newborn screening market is witnessing robust growth, with revenue increasing from 980 Million USD in 2020 to 1,370 Million USD in 2025, ultimately projected to reach 2,230 Million USD by 2035. This growth trajectory is attributed to increased test volumes, expanding screening panels, and greater public health investments. The upward trend underscores the region's commitment to improving neonatal health outcomes through early and comprehensive diagnostic programs, further supported by rapid technological innovation.
Key Drivers
Rising prevalence of congenital disorders and mandatory government regulations across the US and Canada are driving hospitals and laboratories to boost screening volumes. In 2024, PerkinElmer Inc. expanded its reagent kit offerings to meet regulatory inclusions for Cystic Fibrosis and Sickle Cell Disease screening.
Key Trends
Adoption of multiplex testing technologies is accelerating, allowing simultaneous screening for multiple metabolic and genetic disorders. Bio-Rad Laboratories Inc. introduced a multi-analyte panel in 2024 to streamline workflows and reduce sample-to-answer time for clinics.
Expansion of point-of-care screening, including pulse oximetry and portable hearing tests, is enhancing coverage in rural and community settings. Masimo Corporation announced a new generation of pulse oximeters in June 2024, optimized for neonatal accuracy.
Market Insights & Segmentation
Type (Blood Tests, Hearing Screening, Pulse Oximetry, Genetic Testing, Critical Congenital Heart Disease Screening, Other Types),
Application (Dry Blood Spot Screening, Hearing Screening, Cystic Fibrosis, Sickle Cell Disease, Critical Congenital Heart Disease, Other Applications),
Distribution Channels (Hospitals, Diagnostic Centers, Clinics, Laboratories, Specialty Centers, Other Distribution Channels),
Technology (Tandem Mass Spectrometry, Immunoassays & Enzymatic Assays, Pulse Oximetry, Molecular Assays, Hearing Screening Technology, Other Technologies),
Organization Size (Small, Medium, Large)
Key Market Companies
PerkinElmer Inc.,Natus Medical Incorporated,Bio-Rad Laboratories Inc.,Trivitron Healthcare,Masimo Corporation,Medtronic Plc,Thermo Fisher Scientific Inc.,Baebies Inc.,Demant A/S,Centogene N.V.,BioVision Technologies,Agilent Technologies Inc.,BioTek Instruments Inc.,AB Sciex,MedScreen Inc.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐚𝐠𝐞𝐬- https://lnkd.in/dQArJyYY

Comments
Post a Comment